178 related articles for article (PubMed ID: 32543972)
21. Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens.
Xu S; Ahmed LU; Stuckert MR; McGinnis KR; Liu Y; Tan M; Huang P; Zhong W; Zhao D; Jiang X; Kennedy MA
PLoS Pathog; 2020 Mar; 16(3):e1008386. PubMed ID: 32208455
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional characterization of bovine G1P[5] rotavirus VP8* protein.
Dang L; Su Y; Qi J; Wu Z; Li D; Wang M; Zhang Q; Wang H; Bai R; Duan Z; Sun X
Virology; 2021 Nov; 563():116-125. PubMed ID: 34509703
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Sialic Acid-Independent Simian Rotavirus Mutants in Viral Infection and Pathogenesis.
Yamasaki M; Kanai Y; Wakamura Y; Kotaki T; Minami S; Nouda R; Nurdin JA; Kobayashi T
J Virol; 2023 Jan; 97(1):e0139722. PubMed ID: 36602365
[TBL] [Abstract][Full Text] [Related]
24. Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants.
Liu Y; Huang P; Jiang B; Tan M; Morrow AL; Jiang X
PLoS One; 2013; 8(11):e78113. PubMed ID: 24244290
[TBL] [Abstract][Full Text] [Related]
25. A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses.
Xia M; Huang P; Jiang X; Tan M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33419150
[TBL] [Abstract][Full Text] [Related]
26. Glycan recognition in globally dominant human rotaviruses.
Hu L; Sankaran B; Laucirica DR; Patil K; Salmen W; Ferreon ACM; Tsoi PS; Lasanajak Y; Smith DF; Ramani S; Atmar RL; Estes MK; Ferreon JC; Prasad BVV
Nat Commun; 2018 Jul; 9(1):2631. PubMed ID: 29980685
[TBL] [Abstract][Full Text] [Related]
27. Structural Basis of Glycan Recognition of Rotavirus.
Sun X; Li D; Duan Z
Front Mol Biosci; 2021; 8():658029. PubMed ID: 34307449
[TBL] [Abstract][Full Text] [Related]
28. VP7 and VP8* genetic characterization of group A rotavirus genotype G12P[8]: Emergence and spreading in the Eastern Brazilian coast in 2014.
da Silva MF; Fumian TM; de Assis RM; Fialho AM; Carvalho-Costa FA; da Silva Ribeiro de Andrade J; Leite JP
J Med Virol; 2017 Jan; 89(1):64-70. PubMed ID: 27322509
[TBL] [Abstract][Full Text] [Related]
29. Genetic diversity of G1P[8] rotavirus VP7 and VP8* antigens in Finland over a 20-year period: No evidence for selection pressure by universal mass vaccination with RotaTeq® vaccine.
Hemming M; Vesikari T
Infect Genet Evol; 2013 Oct; 19():51-8. PubMed ID: 23831933
[TBL] [Abstract][Full Text] [Related]
30. Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen.
Hu L; Crawford SE; Czako R; Cortes-Penfield NW; Smith DF; Le Pendu J; Estes MK; Prasad BV
Nature; 2012 Apr; 485(7397):256-9. PubMed ID: 22504179
[TBL] [Abstract][Full Text] [Related]
31. Modeling of the rotavirus group C capsid predicts a surface topology distinct from other rotavirus species.
Eren E; Zamuda K; Patton JT
Virology; 2016 Jan; 487():150-62. PubMed ID: 26524514
[TBL] [Abstract][Full Text] [Related]
32. Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy.
Jiang X; Liu Y; Tan M
Emerg Microbes Infect; 2017 Apr; 6(4):e22. PubMed ID: 28400594
[TBL] [Abstract][Full Text] [Related]
33. An Effective Platform for Exploring Rotavirus Receptors by Bacterial Surface Display System.
Liu D; Geng H; Zhang Z; Xing Y; Yang D; Liu Z; Wang D
Virol Sin; 2020 Feb; 35(1):103-109. PubMed ID: 31777010
[TBL] [Abstract][Full Text] [Related]
34. Structural Basis of Glycan Recognition in Globally Predominant Human P[8] Rotavirus.
Sun X; Dang L; Li D; Qi J; Wang M; Chai W; Zhang Q; Wang H; Bai R; Tan M; Duan Z
Virol Sin; 2020 Apr; 35(2):156-170. PubMed ID: 31620994
[TBL] [Abstract][Full Text] [Related]
35. Histo-blood group antigens: a common niche for norovirus and rotavirus.
Tan M; Jiang X
Expert Rev Mol Med; 2014 Mar; 16():e5. PubMed ID: 24606759
[TBL] [Abstract][Full Text] [Related]
36. Genetic variability of VP7, VP4, VP6 and NSP4 genes of common human G1P[8] rotavirus strains circulating in Italy between 2010 and 2014.
Ianiro G; Delogu R; Fiore L; Ruggeri FM;
Virus Res; 2016 Jul; 220():117-28. PubMed ID: 27130628
[TBL] [Abstract][Full Text] [Related]
37. Glycan-mediated interactions between bacteria, rotavirus and the host cells provide an additional mechanism of antiviral defence.
Raev SA; Omwando AM; Guo Y; Raque MS; Amimo JO; Saif LJ; Vlasova AN
Benef Microbes; 2022 Nov; 13(5):383-396. PubMed ID: 36239669
[TBL] [Abstract][Full Text] [Related]
38. Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses.
Yu Y; Lasanajak Y; Song X; Hu L; Ramani S; Mickum ML; Ashline DJ; Prasad BV; Estes MK; Reinhold VN; Cummings RD; Smith DF
Mol Cell Proteomics; 2014 Nov; 13(11):2944-60. PubMed ID: 25048705
[TBL] [Abstract][Full Text] [Related]
39. High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain.
Monnier N; Higo-Moriguchi K; Sun ZY; Prasad BV; Taniguchi K; Dormitzer PR
J Virol; 2006 Feb; 80(3):1513-23. PubMed ID: 16415027
[TBL] [Abstract][Full Text] [Related]
40. Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
Lee B; Dickson DM; deCamp AC; Ross Colgate E; Diehl SA; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Taniuchi M; Petri WA; Haque R; Qadri F; Kirkpatrick BD
J Infect Dis; 2018 Apr; 217(9):1399-1407. PubMed ID: 29390150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
